pramipexole has been researched along with interleukin-1beta (163-171) in 1 studies
| Studies (pramipexole) | Trials (pramipexole) | Recent Studies (post-2010) (pramipexole) | Studies (interleukin-1beta (163-171)) | Trials (interleukin-1beta (163-171)) | Recent Studies (post-2010) (interleukin-1beta (163-171)) |
|---|---|---|---|---|---|
| 1,103 | 219 | 517 | 192 | 3 | 74 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dutra, RC; Felipetti, FA; Gonçalves, ECD; Horewicz, VV; Lieberknecht, V; Martins, DF; Rabelo, BD; Rodrigues, ALS | 1 |
1 other study(ies) available for pramipexole and interleukin-1beta (163-171)
| Article | Year |
|---|---|
Dopaminergic Receptors as Neuroimmune Mediators in Experimental Autoimmune Encephalomyelitis.
Topics: Anhedonia; Animals; Axons; Brain-Derived Neurotrophic Factor; Corpus Striatum; Depression; Disease Progression; Drug Evaluation, Preclinical; Encephalomyelitis, Autoimmune, Experimental; Female; Interleukin-1beta; Lymph Nodes; Mice; Mice, Inbred C57BL; Neuroinflammatory Diseases; Oxidative Stress; Peptide Fragments; Pramipexole; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Single-Blind Method; Spinal Cord | 2021 |